Tivdak gets FDA full approval for recurrent or metastatic cervical cancer
The full approval is based on positive results from global Phase 3 innovaTV 301 study that showed overall…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 Apr 24
The full approval is based on positive results from global Phase 3 innovaTV 301 study that showed overall…
30 Apr 24
Enhertu demonstrated a statistically significant and clinically meaningful improvement in PFS against standard-of-care chemotherapy in the primary trial…
30 Apr 24
The approval was based on the findings from the 4WHIM Phase 3 clinical trial in which treatment with…
30 Apr 24
RescEU is part of the EU Civil Protection Mechanism, established by the European Commission as a safety net…
30 Apr 24
This collaboration underscores Merck KGaA, Darmstadt, Germany and Huma's joint commitment to advancing patient-directed care and empowering patients…
29 Apr 24
The approval was based on the results from the Phase 3 BENEGENE-2 study in which Beqvez demonstrated non-inferiority…
29 Apr 24
Apollo 24|7 has also entered into a framework agreement to gradually integrate 100% of Keimed, an Indian wholesale…
29 Apr 24
Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced…
26 Apr 24
The “strategic productivity initiative” to be executed by the American pharmaceutical company will also involve reducing management layers,…
26 Apr 24
The binding offer consists of an upfront cash payment of €190m and up to €85m in potential earnout…